Strong evidence supports the existence of a discontinuation syndrome following the
withdrawal of antidepressant medication, particularly second-generation antidepressants …

Antidepressant and anxiolytic medications are widely prescribed and used by pregnant
women for acute and maintenance therapy. These drugs are able to pass the placental …

A revision of the 2008 British Association for Psychopharmacology evidence-based
guidelines for treating depressive disorders with antidepressants was undertaken in order to …

Depression is the most common complication of childbirth and results in adverse health
outcomes for both mother and child. It is vital, therefore, that health professionals be ready to …

Selective serotonin reuptake inhibitors (SSRIs) are frequently used to treat depression
during pregnancy. Various concerns have been raised about the possible effects of these …

Depression is common in pregnancy and associated with increased risk of adverse effects
for the neonate. Treatment and prevention options include antidepressant therapy. The aim …

The use of antidepressants during pregnancy benefits the mother's well-being, but the
effects of such substances on neurodevelopment remain poorly understood. Moreover, the …

Introduction: The initiative of a consensus on the topic of antidepressant and anxiolytic drug
use in pregnancy is developing in an area of clinical uncertainty. Although many studies …

ABSTRACT Introduction: The World Health Organization recommends newborns to be
breastfed but this may be challenging if the mother needs to be treated for depression, since …

Depression is a recurrent illness in which afflicted individuals have an increased risk for
recurrence as a function of a greater number of previous episodes. Consequently …